BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  Tripos Announces Initial Minimum Liquidating Distribution of $0.47 per Share Payable Nov. 13, 2007; $3.9 Million to Be Transferred to Liquidating Trust

  October 26, 2007

   · 

  1 min read
• Galapagos NV Creates New Warrant Plan

  October 26, 2007

   · 

  1 min read
• Business

  Cerus Corporation Elects Gail Schulze to Board of Directors

  October 26, 2007

   · 

  1 min read
• Business

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Appoints Two Senior Executives

  October 26, 2007

   · 

  3 min read
• Business

  Endologix Inc. Reports Third Quarter Results

  October 26, 2007

   · 

  1 min read
• Drug Development

  Ark Therapeutics to Conduct Pilot Phase III for Vitorto Finalise SPA

  October 26, 2007

   · 

  1 min read
• Drug Development

  UCB Group Announces Initiation of Phase III Clinical Program for RikeltaTM (brivaracetam) as Adjunctive Treatment in Partial-Onset Epilepsy

  October 26, 2007

   · 

  1 min read
• Business

  Recordati S.p.A: Positive First Nine Months 2007 Results, Sales and Margins Grow

  October 26, 2007

   · 

  1 min read
• Deals

  NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) (Jobs) Raises $20 Million in IPO at $4 Per Share

  October 26, 2007

   · 

  4 min read
• Drug Development

  Penwest Pharmaceutical Completes Patient Enrollment in Phase IIa Clinical Study of Nalbuphine ER

  October 26, 2007

   · 

  1 min read